Evidence map›Paper›PMID 37447055›Full record

ArticlePlants (Basel, Switzerland)2023

Therapeutic Effects of Plant Extracts of

Chi-Feng Cheng, Chen-Wen Lu, Wen-Jhen Wu, Li-Yu Su, Thi Kim Ngan Nguyen, Szu-Chuan Shen, Chia-Ying Lien, Wu-Chang Chuang, Ming-Chung Lee, Chung-Hsin Wu

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. De Novo Transcriptome Assembly ofPlants (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chi-Feng ChengSchool of Life Science, National Taiwan Normal University, Taipei 106, Taiwan.
Chen-Wen LuSchool of Life Science, National Taiwan Normal University, Taipei 106, Taiwan.
Wen-Jhen WuSchool of Life Science, National Taiwan Normal University, Taipei 106, Taiwan.
Li-Yu SuDepartment of Physiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Thi Kim Ngan NguyenSchool of Life Science, National Taiwan Normal University, Taipei 106, Taiwan.
Szu-Chuan ShenSchool of Life Science, National Taiwan Normal University, Taipei 106, Taiwan.
Chia-Ying LienMaster Program of Sport Facility Management and Health Promotion, National Taiwan University, Taipei 106, Taiwan.
Wu-Chang ChuangSun Ten Pharmaceutical Co. Ltd., New Taipei City 231, Taiwan.
Ming-Chung LeeBrion Research Institute of Taiwan, New Taipei City 231, Taiwan.
Chung-Hsin WuSchool of Life Science, National Taiwan Normal University, Taipei 106, Taiwan.ORCID 0000-0002-4470-2448
National Taiwan Normal University · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common cancer in women, and chemotherapy is an effective treatment. However, chemotherapy often causes adverse side effects such as cardiotoxicity, myelosuppression, immunodeficiency, and osteoporosis. Our study focused on the alleviating effects of

Indexed as

breast cancercardiotoxicitychemotherapy relieverdoxorubicinimmunodeficiencymicemyelosuppressionosteoporosis

Identifiers

PMID37447055
PMCPMC10346958
OpenAlexW4382789665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.